Cargando…

Unsupervised field-based exercise challenge tests to support the detection of exercise-induced lower airway dysfunction in athletes

BACKGROUND: Athletes are at risk for developing exercise-induced lower airway narrowing. The diagnostic assessment of such lower airway dysfunction (LAD) requires an objective bronchial provocation test (BPT). OBJECTIVES: Our primary aim was to assess if unsupervised field-based exercise challenge t...

Descripción completa

Detalles Bibliográficos
Autores principales: Reier-Nilsen, Tonje, Stang, Julie Sørbø, Flatsetøy, Hanne, Isachsen, Martine, Ljungberg, Henrik, Bahr, Roald, Nordlund, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373716/
https://www.ncbi.nlm.nih.gov/pubmed/37520311
http://dx.doi.org/10.1136/bmjsem-2023-001680
Descripción
Sumario:BACKGROUND: Athletes are at risk for developing exercise-induced lower airway narrowing. The diagnostic assessment of such lower airway dysfunction (LAD) requires an objective bronchial provocation test (BPT). OBJECTIVES: Our primary aim was to assess if unsupervised field-based exercise challenge tests (ECTs) could confirm LAD by using app-based spirometry. We also aimed to evaluate the diagnostic test performance of field-based and sport-specific ECTs, compared with established eucapnic voluntary hyperpnoea (EVH) and methacholine BPT. METHODS: In athletes with LAD symptoms, sensitivity and specificity analyses were performed to compare outcomes of (1) standardised field-based 8 min ECT at 85% maximal heart rate with forced expiratory volume in 1 s (FEV(1)) measured prechallenge and 1 min, 3 min, 5 min, 10 min, 15 min and 30 min postchallenge, (2) unstandardised field-based sport-specific ECT with FEV(1) measured prechallenge and within 10 min postchallenge, (3) EVH and (4) methacholine BPT. RESULTS: Of 60 athletes (median age 17.5; range 16–28 years.; 40% females), 67% performed winter-sports, 43% reported asthma diagnosis. At least one positive BPT was observed in 68% (n=41/60), with rates of 51% (n=21/41) for standardised ECT, 49% (n=20/41) for unstandardised ECT, 32% (n=13/41) for EVH and methacholine BPT, while both standardised and unstandardised ECTs were simultaneously positive in only 20% (n=7/35). Standardised and unstandardised ECTs confirmed LAD with 54% sensitivity and 70% specificity, and 46% sensitivity and 68% specificity, respectively, using EVH as a reference, while EVH and methacholine BPT were both 33% sensitive and 85% specific, using standardised ECTs as reference. CONCLUSION: App-based spirometry for unsupervised field-based ECTs may support the diagnostic process in athletes with LAD symptoms. TRIAL REGISTRATION NUMBER: NCT04275648.